-
Je něco špatně v tomto záznamu ?
The role of gut microbiota in intestinal and liver diseases
T. Hrncir, L. Hrncirova, M. Kverka, H. Tlaskalova-Hogenova,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, přehledy
Grantová podpora
NV15-28064A
MZ0
CEP - Centrální evidence projektů
NV15-30782A
MZ0
CEP - Centrální evidence projektů
NV17-31248A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Plný text - Článek
Plný text - Článek
Zdroj
Zdroj
NLK
Free Medical Journals
od 1967 do Před 4 lety
SAGE Journals
od 1999-01-01
PubMed
30580671
DOI
10.1177/0023677218818605
Knihovny.cz E-zdroje
- MeSH
- dysbióza mikrobiologie patofyziologie MeSH
- gnotobiologické modely fyziologie MeSH
- modely nemocí na zvířatech MeSH
- myši MeSH
- nemoci jater mikrobiologie patofyziologie MeSH
- nemoci střev mikrobiologie patofyziologie MeSH
- střevní mikroflóra fyziologie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The world-wide incidence of many immune-mediated and metabolic diseases, including those of the intestines and liver, is steadily increasing. Gut microbiota plays a central role in the pathogenesis of these diseases as it mediates environmental changes to the intestinal immune system. Various environmental factors including diet, food additives and medication also trigger the compositional and functional alterations of microbiota, that is, dysbiosis, and this dysbiosis is closely associated with many chronic inflammatory diseases. However, the causal relationship remains unclear for the majority of these diseases. In this review, we discuss essential epidemiological data, known pathogenetic factors including those of genetic and environmental nature, while mainly focusing on the role of gut microbiota in the development of selected intestinal and liver diseases. Using specific examples, we also briefly describe some of the most widely-used animal models including gnotobiotic models and their contribution to the research of pathogenetic mechanisms of the host-microbiota relationship.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034855
- 003
- CZ-PrNML
- 005
- 20201102160731.0
- 007
- ta
- 008
- 191007s2019 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1177/0023677218818605 $2 doi
- 035 __
- $a (PubMed)30580671
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Hrncir, Tomas $u 1 Institute of Microbiology, The Czech Academy of Sciences, Czech Republic.
- 245 14
- $a The role of gut microbiota in intestinal and liver diseases / $c T. Hrncir, L. Hrncirova, M. Kverka, H. Tlaskalova-Hogenova,
- 520 9_
- $a The world-wide incidence of many immune-mediated and metabolic diseases, including those of the intestines and liver, is steadily increasing. Gut microbiota plays a central role in the pathogenesis of these diseases as it mediates environmental changes to the intestinal immune system. Various environmental factors including diet, food additives and medication also trigger the compositional and functional alterations of microbiota, that is, dysbiosis, and this dysbiosis is closely associated with many chronic inflammatory diseases. However, the causal relationship remains unclear for the majority of these diseases. In this review, we discuss essential epidemiological data, known pathogenetic factors including those of genetic and environmental nature, while mainly focusing on the role of gut microbiota in the development of selected intestinal and liver diseases. Using specific examples, we also briefly describe some of the most widely-used animal models including gnotobiotic models and their contribution to the research of pathogenetic mechanisms of the host-microbiota relationship.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a dysbióza $x mikrobiologie $x patofyziologie $7 D064806
- 650 _2
- $a střevní mikroflóra $x fyziologie $7 D000069196
- 650 _2
- $a gnotobiologické modely $x fyziologie $7 D005856
- 650 _2
- $a nemoci střev $x mikrobiologie $x patofyziologie $7 D007410
- 650 _2
- $a nemoci jater $x mikrobiologie $x patofyziologie $7 D008107
- 650 _2
- $a myši $7 D051379
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Hrncirova, Lucia $u 1 Institute of Microbiology, The Czech Academy of Sciences, Czech Republic. 2 Faculty of Medicine, Charles University, Czech Republic.
- 700 1_
- $a Kverka, Miloslav $u 1 Institute of Microbiology, The Czech Academy of Sciences, Czech Republic.
- 700 1_
- $a Tlaskalova-Hogenova, Helena $u 1 Institute of Microbiology, The Czech Academy of Sciences, Czech Republic.
- 773 0_
- $w MED00003110 $t Laboratory animals $x 1758-1117 $g Roč. 53, č. 3 (2019), s. 271-280
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30580671 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20201102160730 $b ABA008
- 999 __
- $a ok $b bmc $g 1451515 $s 1073405
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 53 $c 3 $d 271-280 $e 20181222 $i 1758-1117 $m Laboratory animals $n Lab Anim $x MED00003110
- GRA __
- $a NV15-28064A $p MZ0
- GRA __
- $a NV15-30782A $p MZ0
- GRA __
- $a NV17-31248A $p MZ0
- LZP __
- $a Pubmed-20191007